Literature DB >> 18181547

Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design.

Ajay B Solanki1, Jolly R Parikh, Rajesh H Parikh.   

Abstract

The aim of this study was to investigate the combined influence of 3 independent variables in the preparation of piroxicam proniosomes by the slurry method. A 3-factor, 3-level Box-Behnken design was used to derive a second-order polynomial equation and construct contour plots to predict responses. The independent variables selected were molar ratio of Span 60:cholesterol (X(1)), surfactant loading (X(2)), and amount of drug (X(3)). Fifteen batches were prepared by the slurry method and evaluated for percentage drug entrapment (PDE) and vesicle size. The transformed values of the independent variables and the PDE (dependent variable) were subjected to multiple regression to establish a full-model second-order polynomial equation. F was calculated to confirm the omission of insignificant terms from the full-model equation to derive a reduced-model polynomial equation to predict the PDE of proniosome-derived niosomes. Contour plots were constructed to show the effects of X(1), X(2) and X(3) on the PDE. A model was validated for accurate prediction of the PDE by performing checkpoint analysis. The computer optimization process and contour plots predicted the levels of independent variables X(1), X(2), and X(3) (0, -0.158 and -0.158 respectively), for maximized response of PDE with constraints on vesicle size. The Box-Behnken design demonstrated the role of the derived equation and contour plots in predicting the values of dependent variables for the preparation and optimization of piroxicam proniosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18181547      PMCID: PMC2750377          DOI: 10.1208/pt0804086

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

1.  Physical and chemical evaluation of liposomes, containing artesunate.

Authors:  M Gabriëls; J Plaizier-Vercammen
Journal:  J Pharm Biomed Anal       Date:  2003-03-26       Impact factor: 3.935

Review 2.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury.

Authors:  D R Janero
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

Review 3.  Recent aspects in the use of liposomes in biotechnology and medicine.

Authors:  T Sato; J Sunamoto
Journal:  Prog Lipid Res       Date:  1992       Impact factor: 16.195

4.  Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.

Authors:  Minakshi Garg; Abhay Asthana; Hrushikesh B Agashe; Govind Prasad Agrawal; Narendra Kumar Jain
Journal:  J Pharm Pharmacol       Date:  2006-05       Impact factor: 3.765

5.  The detection of oxidation in liposome preparations.

Authors:  R A Klein
Journal:  Biochim Biophys Acta       Date:  1970-09-08

6.  Rapid separation of low molecular weight solutes from liposomes without dilution.

Authors:  D W Fry; J C White; I D Goldman
Journal:  Anal Biochem       Date:  1978-10-15       Impact factor: 3.365

7.  Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori.

Authors:  R B Umamaheshwari; N K Jain
Journal:  J Drug Target       Date:  2003-08       Impact factor: 5.121

Review 8.  Oxidative stress. Biochemistry and human disease.

Authors:  A Bast; R J Goris
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

9.  Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages.

Authors:  J Haensler; F Schuber
Journal:  Biochim Biophys Acta       Date:  1988-12-08

Review 10.  Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives.

Authors:  Reza Mehvar
Journal:  Curr Pharm Biotechnol       Date:  2003-10       Impact factor: 2.837

View more
  18 in total

1.  Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

Authors:  Ahmed A Aboelwafa; Emad B Basalious
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Basic red 2 and methyl violet adsorption by date pits: adsorbent characterization, optimization by RSM and CCD, equilibrium and kinetic studies.

Authors:  Manel Wakkel; Besma Khiari; Féthi Zagrouba
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-22       Impact factor: 4.223

3.  Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

Authors:  Di Bei; Jacob Marszalek; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2009-08-11       Impact factor: 3.246

4.  Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

Authors:  Di Bei; Jacob Marszalek; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2009-08-18       Impact factor: 3.246

5.  Formulation and evaluation of Adapalene-loaded nanoparticulates for epidermal localization.

Authors:  Mangesh Bhalekar; Prashant Upadhaya; Ashwini Madgulkar
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

Review 6.  Polymers in Technologies of Additive and Inkjet Printing of Dosage Formulations.

Authors:  Evgenia V Blynskaya; Sergey V Tishkov; Konstantin V Alekseev; Alexandre A Vetcher; Anna I Marakhova; Dovlet T Rejepov
Journal:  Polymers (Basel)       Date:  2022-06-22       Impact factor: 4.967

7.  Formulation and evaluation of proniosomes containing lornoxicam.

Authors:  Jyotsana R Madan; Nitesh P Ghuge; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

8.  Developing micro-/nanoparticulate drug delivery systems using "design of experiments".

Authors:  Bhupinder Singh; Rahul Bhatowa; Chandra Bhushan Tripathi; Rishi Kapil
Journal:  Int J Pharm Investig       Date:  2011-04

9.  Optimization of the experimental parameters of fluticasone propionate microparticles for pulmonary delivery using a box behenken design.

Authors:  P V Patel; T G Soni; V T Thakkar; T R Gandhi
Journal:  J Pharm Bioallied Sci       Date:  2012-03

10.  Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design.

Authors:  Aviral Jain; Sanjay K Jain
Journal:  Biomatter       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.